Bird Flu: China Sees First Human Case Of Rare H10N3 Strain

This post was shared from the's RSS feed

In the early years of the twenty-first century there was widespread global concern over outbreaks of so-called bird flu. In 2005 the United Nations even claimed that a bird flu pandemic could kill up to 150 million people. Fortunately, this didn’t happen. Nevertheless, since that time, strains of bird flu viruses have continued to infect humans and multiple deaths have been reported.

In the current political climate, given the global state of panic that has ensued over the coronavirus pandemic, it is inevitable that any new viral outbreak – or even a serious threat of one – would be instrumentalized by stakeholders of the pharmaceutical industry and used to facilitate the rapid development of new experimental vaccines. We have written previously about the health risks posed by the current generation of genetically engineered vaccines against COVID-19, for which no long-term safety data exists.

In an Open Letter published in the New York Times in 2006, Dr. Rath described how micronutrient-based approaches could provide effective, safe, and affordable alternatives for fighting bird flu infections. Based on research carried out at the Dr. Rath Research Institute at that time, it was already then possible for governments to use these scientific approaches to improve the health of their citizens and develop public health strategies for fighting bird flu outbreaks. This still remains the case today.

To read more about the Dr. Rath Research Institute’s research on natural approaches to combating bird flu infections, see this article on our website.